Westfield Capital Management increased stake in Ironwood Pharmaceuticals, Inc. By Investing.com

© Reuters. Westfield Capital Management increased stake in Ironwood Pharmaceuticals, Inc.

On the 31st of December, Westfield Capital Management added 3.1 million Ironwood Pharmaceuticals, Inc. (IRWD) shares for $36 million at an average price of $11.39 per share.
Shares of Ironwood Pharmaceuticals, Inc. are up 0.88% since the transaction.

Westfield Capital Management’s holding in Ironwood Pharmaceuticals, Inc. increased to about 8.5 million shares with the purchase.

Westfield Capital Management first bought Ironwood Pharmaceuticals, Inc. stock in the second quarter of 2018.
Westfield Capital Management also owns Bristol-Myers Squibb Co (NYSE:), Thermo Fisher Scientific Inc (NYSE:), Bio-Rad Laboratories Inc (NYSE:) and Blueprint Medicines Corp (NASDAQ:).
Ironwood Pharmaceuticals, Inc. is its number two position by number of shares and market value among biotechnology & life sciences stocks.

Other investors who also added to their Ironwood Pharmaceuticals, Inc. shares include California State Teachers Retirement System, Victory Capital Management, and Gotham Asset Management.
In contrast, Fisher Asset Management, Millennium Management, and the T. Rowe Price Equity Income Fund reduced IRWD shares, while Royce & Associates sold all their IRWD shares.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Be the first to comment

Leave a Reply

Your email address will not be published.


*